Latest Eribulin Stories
Eribulin (trade name: Halaven®) was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy.
- Partnership Based on Open Innovation That Leverages Eisai's Natural Product Chemistry-Based Drug Discovery Platform -Tokyo, July 17, 2012 - (JCN Newswire) - Eisai Co., Ltd.
Tokyo, Apr 23, 2012 - (JCN Newswire) - Eisai Co., Ltd.
- The act of sweetening by admixture of some saccharine substance.